🔴 Cue Biopharma is trading 10.1% down today as it reverses from recent highs amid broader biotech weakness

Cue Biopharma is trading at $27.34 (-10.08%) as it reverses sharply from its July 30 close of $30.40 despite a lack of fresh company-specific news.

• The move appears to be a technical pullback, though the decline significantly outpaces the broader biotech sector's performance.
• The XBI is down 3.15%, suggesting a sector-wide drag, but the magnitude of the drop in Cue Biopharma indicates additional selling pressure may be involved.